Geovax Labs Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | - | Sales 2025 * | 24.3M 1.92B | Capitalization | 8.29M 655M |
---|---|---|---|---|---|
Net income 2024 * | -31M -2.45B | Net income 2025 * | -25M -1.97B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-1.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Geovax Labs Inc
Managers | Title | Age | Since |
---|---|---|---|
David Dodd
CEO | Chief Executive Officer | 74 | 16/03/10 |
Mark Reynolds
DFI | Director of Finance/CFO | 62 | 30/09/06 |
Erica Raiden
CTO | Chief Tech/Sci/R&D Officer | - | 06/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert McNally
BRD | Director/Board Member | 76 | 30/11/06 |
Randal Chase
BRD | Director/Board Member | 74 | 18/03/15 |
John Spencer
BRD | Director/Board Member | 83 | 27/09/06 |
1st Jan change | Capi. | |
---|---|---|
+16.41% | 44.44B | |
-9.88% | 37.99B | |
+37.55% | 37.75B | |
+29.72% | 30.78B | |
-8.44% | 27.38B | |
+12.29% | 26.17B | |
+44.75% | 14.15B | |
+32.22% | 12.59B | |
-7.41% | 11.28B |